MoneyWorks4Me

With reference to the news article in The Economic Times, on July 22, 2015 captioned ‘Aurobindo Pharma Comes Under US FDA Lens’, Aurobindo Pharma has Clarified that the said facility underwent a routine GMP inspection by USFDA and there are certain observations related to the systems and procedures. The Company is appropriately responding and this has no perceived impact on the operations and exports from the said facility.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..